Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flu Vaccine Efficacy in Metabolic Syndrome
NCT02653495Terminated
- Sponsor
- The Rockefeller University
- Start
- Jan 2016
- Primary completion
- Mar 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of influenza vaccine in influenza, sponsored by The Rockefeller University. Primary endpoint: Antibody Response at 28 days. Started Jan 2016; status: terminated.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02653495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653495.